About CBM Biopharma
CBM Biopharma is a company based in Dallas (United States) founded in 2018 was acquired by AIkido Pharma in June 2019. CBM Biopharma operates in a competitive market with competitors including Jazz Pharmaceuticals, BridgeBio, Spark Therapeutics, Alnylam and ATAI, among others.
- Headquarter Dallas, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
AIkido Pharma
(Jun 19, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of CBM Biopharma
Detailed funding history for CBM Biopharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in CBM Biopharma
CBM Biopharma has secured backing from 1 investor. Prominent investors backing the company include AIkido Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Drugs for treating pancreatic cancer and leukemia are developed.
|
Locked | Locked | Locked |
Investor details for CBM Biopharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CBM Biopharma
Investment portfolio details for CBM Biopharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CBM Biopharma
Detailed financials for CBM Biopharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cbm Biopharma Comparisons
Peer comparison for CBM Biopharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CBM Biopharma
CBM Biopharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, BridgeBio, Spark Therapeutics, Alnylam and ATAI, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| Locked | Locked | Locked |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| Locked | Locked | Locked |
RNA interference-based therapeutics are developed for multiple disorders.
|
|
| Locked | Locked | Locked |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| Locked | Locked | Locked |
An AI-enabled platform is developed for infectious disease treatment.
|
Detailed competitors of CBM Biopharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cbm Biopharma
Complete news archive for CBM Biopharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CBM Biopharma
CBM Biopharma was founded in 2018.
CBM Biopharma is headquartered in Dallas, United States. It is registered at Dallas, Texas, United States.
CBM Biopharma was founded in 2018 in Dallas, United States, and operates in the biopharmaceutical sector focused on oncology. Small molecule-based therapeutics are developed to address cancer challenges. The drug candidate KPC34 is designed by combining a DNA damaging agent with targeted therapy to counter resistance mechanisms, targeting acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). DHA-dFdC has also been developed for pancreatic cancer treatment.
CBM Biopharma's top competitors include Jazz Pharmaceuticals, Spark Therapeutics and BridgeBio.
CBM Biopharma has 1 investor. Key investors include AIkido Pharma.